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ABSTRACT: The hetisine-type natural products exhibit one of 
the most complex carbon skeletons within the diterpenoid alkaloid 
family. The use of network analysis has enabled a synthesis strat-
egy to access alkaloids in this class with hydroxylation on the A-
ring. Key transformations include a benzyne acyl-alkylation to con-
struct a key fused 6-7-6 tricycle, a chemoselective nitrile reduction, 
and sequential C–N bond formations using a reductive cyclization 
and a photochemical hydroamination to construct an embedded 
azabicycle. Our strategy may enable access to myriad natural and 
unnatural products within the hetisine-type.  
Voltage-gated sodium (Nav), calcium (Cav), and potassium (Kv) 
channels regulate a wide variety of biophysical responses in the 
nervous, circulatory, and muscular systems.1 As a result, the selec-
tive targeting of ion channels holds great promise for treating a 
number of channelopathies, including Alzheimer’s disease, epi-
lepsy, and chronic pain.2 One of the greatest challenges in the dis-
covery of small molecule modulators of ion channels, particularly 
Nav channels, is to achieve high selectivity in targeting one isoform 
over another.3 For example, targeting Nav1.7 or 1.8 may prove use-
ful in combating chronic pain, but off-target interactions with other 
isoforms leads to serious cognitive, cardiac, or muscular complica-
tions.3a The identification, synthesis, and study of isoform-selective 
ion channel modulators will facilitate a better understanding of the 
interactions responsible for selectivity. 
The diterpenoid alkaloids, a collection of over 1200 natural prod-
ucts isolated from numerous plants in the Aconitum, Delphinium, 
and Consolida genera, show strong affinities for various Nav and 
Kv channels, functioning as either agonists or antagonists.4 This 
Figure 1. Representative diterpenoid alkaloids. 
 
Figure 2. Biosynthetic relationships between selected C20-
diterpenoid alkaloids. 
 
broad range of activity and selectivity arises from relatively subtle 
changes on scaffolds consisting of 18, 19, and 20 carbon atoms. For 
example, despite their overwhelming similarities, the C19-diterpe-
noid alkaloid aconitine (1, Figure 1) is a potent Nav channel activa-
tor, whereas the related C18-diterpenoid alkaloid lappaconitine (2) 
is a Nav channel blocker.5 The C20-diterpenoid alkaloid Guan-fu 
base A (3), another Nav channel blocker, is approved and marketed 
in China for the treatment of arrhythmia.6 Within this family, there 
exist other oxygenated congeners with unexplored activity.7 There-
fore, the ability to access myriad oxygenated diterpenoid alkaloid 
natural products and their associated derivatives would enable stud-
ies to deepen our understanding of the structure-activity relation-
ships across all classes and types. 
Our group’s interest in this class of molecules has culminated in 
the syntheses of several C18- and C19-aconitine-type, as well as C20-
denudatine-type natural products.8,9 Within the C20 family, the he-
tisine-type molecules are the most prevalent, with more than 120 
known members, including 3.10 Of the biosynthetically related atis-
ine-, denudatine-, hetidine-, hetisine- and vakognavine-type natural 
products (Figure 2), the carbon framework of the hetisine-type 
diterpenoid alkaloids (exemplified by cossonidine (8)) is consid-
ered to be the most complex, featuring a C14–C20 bond and an N–
C6 bond, which results in a tertiary amine embedded within a hep-
tacyclic skeleton. Strategies for the syntheses of atisine- and heti-
dine-type diterpenoid alkaloids have been advanced;11–15 however, 
to date, only a single hetisine-type alkaloid—the monohydroxy- 
 Scheme 1. Network-Analysis-Guided Retrosynthesis of Cossonidine 
 
lated nominine (4)—has been accessed through total synthesis by 
Muratake and Natsume16 as well as by Gin and Peese.17 The rela-
tively low number of hetisine syntheses can, in part, be attributed 
to the challenge in forming the N-C6 bond at a late stage through 
chemical synthesis.11a,13 
Cognizant of the fact that most hetisine-type diterpenoid alka-
loids, including the medicinally relevant Guan-fu base A (3), pos-
sess additional oxygenation on the A ring, our group set out to de-
velop a synthesis route to the hetisine framework that would intro-
duce A ring oxygenation, while obviating the challenge associated 
with a late-stage installation of the N-C6 bond. In this Communi-
cation, we report a validation of our approach, which has resulted 
in the first synthesis of cossonidine (8), a hetisine-type alkaloid iso-
lated independently in 1996 by de la Fuente7b and Pelletier7c (who 
termed this natural product davisine). 
By constraining our analysis to a maximum ring size of seven in 
our network-analysis of cossonidine (8),18,19 we identified two 
maximally-bridged ring systems: a carbocyclic 7-membered ring 
and a nitrogen-containing 7-membered ring (highlighted in blue, 
Scheme 1), both of which contain 6 bridging atoms. To achieve 
maximal simplification of the highlighted bridged ring systems, we 
envisioned a bicyclization transform that would alleviate bridging 
atoms in both ring systems, thus leading back to pentacycle 9 con-
taining an alkene and arene functional groups. Network analysis of 
9 revealed the F ring to be maximally-bridged, with 5 bridging at-
oms. Disconnecting the two C–N bonds in 9 using two amination 
transforms effectively simplified the target structure to fused tricy-
cle 10, which exhibits no bridging elements. Forging the seven-
membered ring motif in 10 was envisioned to occur through an 
acyl-alkylation annulation between functionalized benzyne deriva-
tive 11 and β-ketoester 12, which in turn could arise from literature-
reported hydrindanone 13.8,9 
Hydrindanone 13, prepared on multi-gram scale in two steps 
from dienophile 14 and diene 15 according to our previously re-
ported procedures,8,9 served as the starting point for our studies (see 
Scheme 2). LiAlH4-mediated reduction of both the ester and ketone 
groups in 13, followed by Ley oxidation20 provided a ketoaldehyde 
intermediate (not shown). While olefination of the aldehyde under 
standard Wittig conditions led to poor yields of the desired alkene, 
application of Lebel’s Rh-catalyzed methylenation21 effected selec-
tive formation of terminal alkene 16 in 71% yield over 3 steps. Ac-
ylation using allyl cyanoformate (17)22 proceeded in 88% yield to 
provide β-ketoester 12, the substrate for the aryne insertion reac-
tion. Following the precedent of Stoltz and coworkers,23 treatment 
of a mixture of β-ketoester 12 and aryne precursor 1824 with CsF in 
MeCN at 70 °C provided tricycle 19 in 38–45% yields. The bro-
mine atom on the aryne was required to obtain high regioselectivity 
in the acyl-alkylation process, in accordance with studies by Garg 
and Houk.25 This transformation represents one of the most com-
plex applications of the benzyne acyl-alkylation reaction reported 
to date.26 
We next sought to install a functional handle in the form of an 
alkene group at C6 to aid in the formation of the N–C6 bond at a 
Scheme 2. Synthesis and Elaboration of the 6-7-6 Tricycle 
 
 Scheme 3. Assembly of the Heptacyclic Core of the Hetisine-type Alkaloids and Completion of Cossonidine 
 
later stage of the synthesis. Thus, deallylation using catalytic 
Pd(PPh3)4 and PhSiH3 provided carboxylic acid 20 in 97–99% 
yield,27 which was characterized by X-ray crystallography. Subse-
quent treatment with 1,3-diiodo-5,5-dimethylhydantoin (DIH) un-
der photochemical conditions effected oxidative decarboxylation28 
to furnish styrenyl derivative 21
 
in 71–74% yield.  
The next challenge was to introduce the methyl group (C18) at 
the C4-position, which is present not only in the hetisine-type, but 
in all the C20-diterpenoid alkaloid natural products. Efforts to intro-
duce this methyl group at earlier stages in the synthesis were un-
successful, resulting in recovered starting material or nonspecific 
decomposition. Ultimately, the primary hydroxyl resulting from 
TBAF-mediated desilylation of 21 (95% yield) was directly con-
verted into nitrile 22 in 96% yield,29 and diastereoselective methyl-
ation of 22 was accomplished in 58% yield by deprotonation with 
LiHMDS followed by addition of methyl iodide. Access to tricyclic 
intermediate 10, bearing functional handles at C6 and C20, set the 
stage for the subsequent C–N bond-forming reactions. 
To construct the azabicycle moiety, we sought to first form the 
N–C20 bond through a global reduction of 10, which we envisioned 
would convert the nitrile to a primary amine, the ketone to a hy-
droxyl group, and effect removal of the bromine atom. At this stage, 
displacement of the C20-hydroxyl group by the resultant primary 
amine through a Mitsunobu reaction or via an intermediate alkyl 
chloride was expected to forge the piperidine ring (the N–C20 
bond).12b Treatment of 10 with LiAlH4, however, resulted in a com-
plex mixture of products, presumably due to incomplete reduction 
of the nitrile group. We posited that a potential solution would be 
to first chemoselectively reduce the nitrile group in the presence of 
the ketone carbonyl and two alkene groups. This was achieved with 
cobalt boride (Co2B) and borane t-butylamine complex (Scheme 
3).30 Gratifyingly, upon subjecting the resulting primary amine to 
LiAlH4 in THF at reflux, ketone reduction, protodebromination, 
and cyclization to form the N–C20 bond occurred to deliver di-
rectly secondary amine 23. A photochemical hydroamination fur-
nished tertiary amine 9 in 71% yield over 3 steps.31 
At this stage, formation of the [2.2.2] bicycle was explored fol- 
lowing the Birch reduction/intramolecular Diels–Alder sequence 
utilized in the Gin synthesis of nominine.17 Notably, while the cy-
cloaddition performed by Gin and coworker (on an intermediate 
analogous to 24 but lacking the C1-methoxy substituent) proceeded 
in high yield at only 60 °C, the cycloaddition of 24 required signif-
icantly elevated temperatures. The best results were achieved using 
microwave irradiation at 110 °C in 9:1 MeOH/pyrrolidine for 2 h, 
forging the heptacyclic product (25) after hydrolysis in 54% yield 
over 2 steps. We postulate that the steric influence of the equatorial 
C1-methoxy substituent in 24 preferentially orients the vinyl group 
away from the diene, a penalty which is avoided in the Gin sub-
strate lacking the methoxy group. 
With the heptacyclic core assembled, we investigated reaction 
conditions for selective cleavage of the C1 methyl ether. While an 
evaluation of standard Lewis acid-mediated conditions for the 
cleavage of aliphatic methyl ethers proved unsuccessful, exposure 
of ether 25 to HBr in AcOH,9,32 and ensuing treatment with K2CO3 
in methanol provided secondary alcohol 26 in 60% yield over 2 
steps. Under these conditions, a Wagner-Meerwein rearrangement 
product (27), which was umambiguously characterized by X-ray 
crystallography, is also form in 5% yield over 2 steps (see the SI 
for details). Wittig methylenation converted the ketone group of 26 
into the terminal alkene (28) in 85% yield, thereby introducing the 
final carbon atom of the hetisine-type skeleton. An oxidation/re-
duction sequence was then explored to invert the C1-stereocenter. 
Application of Stahl’s aerobic oxidation conditions33 gave the ke-
tone 29 in 81% yield. In a reversal of the typical stereoselectivity 
trend observed in cyclohexanone reductions,34 reacting this ketone 
with LiAlH4 resulted in a diastereoselective reduction (6.6:1 dr) in 
favor of the desired alcohol (30) with the axially-disposed hydroxyl 
group, which was isolated in 81% yield. Subjecting 30 to selenium 
dioxide produced cossonidine (8) and enone 31 in 39% and 19% 
yields, respectively. Reduction of enone 31 under Luche conditions 
resulted in 90% yield of a 3:1 mixture of diastereomers favoring 
15-epi-cossonidine (32). 
In summary, our work has provided access to the complete he-
tisine-type skeleton bearing key functional group handles on both 
the A ring and the [2.2.2] bicycle for further derivatization. This 
 route proceeds in 21 steps from known hydrindanone 13 and fea-
tures a benzyne acyl-alkylation ring expansion, a chemoselective 
nitrile reduction, a light-mediated hydroamination, and an intramo-
lecular Diels–Alder cycloaddition as key steps. With the complex 
hetisine skeleton assembled, future studies will be directed toward 
generating more highly oxygenated congeners.7 Furthermore, by 
starting with enantioenriched hydrindanone 13, which was recently 
reported by our group,8,9 this synthesis should be readily rendered 
enantioselective. 
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